Aquestive Therapeutics Stock Forecast

Hold candidate since Jun 03, 2026

The Aquestive Therapeutics Inc. stock price gained 2.54% on the last trading day (Wednesday, 3rd Jun 2026), rising from $3.93 to $4.03. During the last trading day the stock fluctuated 4.94% from a day low at $3.85 to a day high of $4.04. The price has fallen in 5 of the last 10 days and is down by -1.47% for this period. Volume fell on the last day by -263 thousand shares and in total, 2 million shares were bought and sold for approximately $6.84 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $3.87 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Aquestive Therapeutics Inc. stock with a 90% probability to be traded between $3.86 and $4.71 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

AQST Signals & Forecast

There are mixed signals in the stock today. The Aquestive Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.17. On a fall, the stock will find some support from the short-term average at $4.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 2.54%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Aquestive Therapeutics Inc. stock

Aquestive Therapeutics Inc. finds support from accumulated volume at $4.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.190 between high and low, or 4.94%. For the last week, the stock has had daily average volatility of 3.27%.

Our recommended stop-loss: $3.84 (-4.59%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (AQST) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Aquestive Therapeutics Inc. to open at $3.97, and during the day (based on 14 day Average True Range), to move between $3.94 and $4.12, which gives a possible trading interval of +/-$0.179 (+/-4.55%) up or down from last closing price. If Aquestive Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.02 (0.25%) than the resistance at $4.17 (3.47%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aquestive Therapeutics Inc. stock A Buy?

Aquestive Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.801 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $3.97 ( 1.41%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk